IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 94

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Review on immune agents in treatment of cancer
Authors Name: Akash Anil Sukase , Prasad Gajanan Kalpande , Prajakta Shivnath Vilag , Vaishnavi Babasaheb Zarekar , Shreyash Babasaheb Tribhuvan
Download E-Certificate: Download
Author Reg. ID:
IJNRD_188605
Published Paper Id: IJNRD2303196
Published In: Volume 8 Issue 3, March-2023
DOI:
Abstract: In this article we have to study the oncologic agents which are used in cancer therapy.The immuno oncology is the study of the treatment of human body’s immune system against the cancer .Surgery, Targeted therapy, chemotherapy,and radiotherapy this are the treatments against cancer.In this article review we briefly discussed about cancer,it’s symptoms, risk factors,when we see a doctor,sign and symptoms,and main content is oncologic agents which are treats or used against cancer therapy.Cancer immuno therapy has significantly improved method for cancer patients than the radiotherapy and surgery.Cancer immune therapy gives significant improvement in patients about more survival and good life’s quality as compared to radio therapy.In this article highlights the immune therapy which is briefly earlier the immune oncology is saturate as a important perspective to treatment of a cancer through the inducement of immunity to kill cancer.
Keywords:
Cite Article: "Review on immune agents in treatment of cancer ", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 3, page no.b850-b856, March-2023, Available :http://www.ijnrd.org/papers/IJNRD2303196.pdf
Downloads: 000118751
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2303196
Registration ID: 188605
Published In: Volume 8 Issue 3, March-2023
DOI (Digital Object Identifier):
Page No: b850-b856
Country: Aurangabad, Maharashtra, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2303196
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2303196
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD